ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026

[Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors].

Sören Schnellhardt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.